Limited stage small cell lung carcinoma
Showing 1 - 25 of >10,000
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for
Not yet recruiting
- Limited-stage Small Cell Lung Cancer (LS-SCLC)
- Tifcemalimab injection
- +3 more
-
Jinan, Shandong, ChinaShandong Cancer Hospital & Institute
Oct 18, 2023
Molecular Analysis and Treatment Options of SCLC
Recruiting
- Small-cell Lung Cancer
- +4 more
-
Shanghai, ChinaShanghai Chest Hospital
Jul 6, 2023
Limited Stage Small Cell Lung Cancer, Not Progressed After First-line Chemoradiotherapy Trial in Jinan (TQB2450 Injection +
Recruiting
- Limited Stage Small Cell Lung Cancer
- Not Progressed After First-line Chemoradiotherapy
- TQB2450 Injection + Anlotinib Hydrochloride Capsules
-
Jinan, Shandong, ChinaCancer Hospital Affiliated to Shandong First Medical University
Jul 5, 2023
Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)
Not yet recruiting
- Small Cell Lung Cancer Limited Stage
- Prophylactic cranial irradiation
- +2 more
- (no location specified)
Dec 14, 2022
Limited Stage Small Cell Lung Cancer Trial in Shang'ai (chemo and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy
-
Shang'ai, Shanghai, ChinaShanghai Pulmonary Hospital
Aug 8, 2022
Limited Stage Small Cell Lung Cancer Trial (HLX10, hypofractionated radiotherapy, Prophylactic Cranial Irradiation (PCI))
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- HLX10
- +2 more
- (no location specified)
Jun 29, 2022
Limited Stage Small Cell Lung Cancer Trial in Shanghai (Pamiparib)
Recruiting
- Limited Stage Small Cell Lung Cancer
-
Shanghai, Shanghai, China
- +1 more
Jul 29, 2022
Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)
Recruiting
- Metastatic Non-small Cell Lung Cancer (NSCLC)
- +5 more
- data collection
-
Oldenburg, GermanyPius-Hospital
Jul 20, 2022
Lung Cancer Trial in Manchester (Once daily radiotherapy, Twice daily radiotherapy)
Completed
- Lung Cancer
- Once daily radiotherapy
- Twice daily radiotherapy
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Sep 5, 2022
Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +3 more
- Biopsy
- +4 more
-
Los Angeles, California
- +8 more
Jan 31, 2023
Limited Stage Small Cell Lung Cancer Trial in Guangzhou (Sugemalimab, Placebo)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Sugemalimab
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 12, 2022
Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States
Recruiting
- Invasive Ductal Breast Carcinoma
- +14 more
- Stereotactic body radiotherapy
- Lattice Radiation Therapy
-
Basking Ridge, New Jersey
- +6 more
Apr 20, 2023
Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Tiragolumab, Placebo)
Active, not recruiting
- Carcinoma, Small Cell Lung
- Atezolizumab
- +2 more
-
Beijing City, China
- +20 more
Dec 15, 2022
Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,
Active, not recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +2 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma Trial in Seattle (Bomedemstat, Atezolizumab)
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Limited Stage Lung Small Cell Carcinoma
- Bomedemstat
- Atezolizumab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 30, 2022
Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora
Completed
- Adenocarcinoma of the Lung
- +7 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jan 19, 2022
NSCLC, Metastatic Non Small Cell Lung Cancer, Nsclc Trial in United States (Local ablative therapy, Blood collection to assess
Recruiting
- Non-small Cell Lung Cancer
- +5 more
- Local ablative therapy
- Blood collection to assess for ctDNA
-
Basking Ridge, New Jersey
- +6 more
Jun 20, 2022
Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Carcinoma Trial in United States (radiation,
Recruiting
- Non Small Cell Lung Cancer
- +4 more
- L-SABR
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Dec 20, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Limited Stage Small Cell Lung Cancer Trial in Beijing (Durvalumab)
Recruiting
- Limited Stage Small Cell Lung Cancer
-
Beijing, ChinaBeijing Haidian Hospital
Sep 1, 2021
Small Cell Lung Cancer Limited Stage Trial in Germany (Durvalumab, standard of care)
Recruiting
- Small Cell Lung Cancer Limited Stage
- Durvalumab
- standard of care
-
Löwenstein, Baden-Würtemberg, Germany
- +9 more
May 18, 2022
Non-small Cell Lung Carcinoma, Small Cell Lung Carcinoma Trial in Boston, Newton (Contralateral Esophageal Sparing Technique
Completed
- Non-small Cell Lung Carcinoma
- Small Cell Lung Carcinoma
- Contralateral Esophageal Sparing Technique (CEST)
-
Boston, Massachusetts
- +1 more
Dec 8, 2021
Small-cell Lung Cancer, SCLC, Small Cell Lung Cancer Limited Stage Trial in Baltimore (Hippocampal-sparing Prophylactic Cranial
Completed
- Small-cell Lung Cancer
- +2 more
- Hippocampal-sparing Prophylactic Cranial Irradiation
-
Baltimore, Maryland
- +1 more
Sep 22, 2021
Small Cell Lung Cancer Limited Stage Trial in Tianjin (Concurrent chemoradiotherapy plus anlotinib)
Recruiting
- Small Cell Lung Cancer Limited Stage
- Concurrent chemoradiotherapy plus anlotinib
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
May 7, 2021